(Q37691477)

22 August 2017

1 reference

title

Benefits of moderate weight loss in patients with type 2 diabetes (English)

1 reference

22 August 2017

0 references

Ken Fujioka

1

1 reference

22 August 2017

1 March 2010

1 reference

Diabetes, Obesity and Metabolism

22 August 2017

1 reference

22 August 2017

12

1 reference

22 August 2017

186-194

1 reference

22 August 2017

3

1 reference

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

22 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01155.X

The prevention and treatment of obesity. Application to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01155.X

Medical hazards of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01155.X

Pharmaceutical cost savings of treating obesity with weight loss medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01155.X

Importance of Weight Management in Type 2 Diabetes: Review with Meta-analysis of Clinical Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01155.X

Long-term effects of change in body weight on all-cause mortality. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01155.X

Body weight change, all-cause mortality, and cause-specific mortality in the Multiple Risk Factor Intervention Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01155.X

Metformin monotherapy for type 2 diabetes mellitus

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD002966.PUB3

Identifiers

DOI

10.1111/J.1463-1326.2009.01155.X

1 reference

22 August 2017

1 reference

PubMed ID

20151995